Achieve accurate disease models and more personalized medicine, by recreating human physiology and pathology in a 3D model. Bi/ond’s customizable Organ-on-Chips (OOCs) are built to outperform the limitation of standard in vitro assays.
In the early phase of drug testing, Petri dishes and animals can fall short of predicting what happens inside the human body.
Bi/ond is where biology meets engineering : our intimate working relationship with biologists helped realize the supportive role engineering can play in generating reproducible and accurate biological models. We develop a lab technology for dynamic cell culture environments that allow for more precise drug testing and simulations of any tissue type. We also empower organizations with valid alternatives to the use of animals in testing (3Rs).
Company Details
- Employees
- 5
- Founded
- -
- Address
- Molengraaffsingel 10, Delft,south Holland 2629 Jd,netherlands
- in****@****eam.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gobiond.com
- Keywords
- chip, lifescience, organoids, organonchip, microfluidic, microfabrication, in vitro, innovation, MPS, biotech, 3d Modelling, cancer research, skeletal muscle, tumor tissue, 3Rs, personalized medicine, animal free research, cancer biopsy, disease models, CRO, Toxicology, pharmaceutical.
- HQ
- Delft, South Holland
Bi/ond Questions
Bi/Ond's website is gobiond.com
Bi/Ond's LinkedIn profile is https://nl.linkedin.com/company/biond
Bi/Ond has
5 employees.
View email and phone details for 5
employees at Bi/Ond.
Bi/Ond's industry is
Biotechnology Research
Bi/Ond's top competitors are
Insphero,
Mimetas,
Alveolix,
Tissuse Gmbh,
Cn Bio,
4dcell,
Ncardia,
Hub Organoids,
Emulate, Inc.,
Netri.
Bi/Ond's support email address is info@biondteam.com
Bi/Ond's categories are Biotechnology Research
Bi/Ond's founding year is 2017
